Table 2 Mean scores of scales from the Short Form (SF-36) and the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (QLQ-C30) 12 months after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Presented as the mean values with standard deviations. The mean difference between patients with and without an incisional hernia is presented with 95% confidence interval
Patients with incisional hernia (n = 9) | Patients without incisional hernia (n = 64) | Mean difference | |
|---|---|---|---|
SF-36 | |||
Physical functioning | 82.2 (16.0) | 86.4 (17.6) | − 4.2 (− 16.6; 8.2) |
Role-physical | 38.9 (43.5) | 71.8 (38.2)* | − 32.9 (− 60.6; − 5.3) |
Bodily pain | 81.7 (24.0) | 81.1 (22.7) | 0.6 (− 15.6;16.8) |
Social functioning | 91.7 (14.0) | 87.9 (21.5) | 3.8 (− 11.0; 18.5) |
Role-emotional | 61.1 (35.4) | 81.3 (32.2) | − 20.2 (− 43.4; 3.1) |
EORTC QLQ-C30 | |||
Global health | 85.2 (13.0) | 77.1 (19.7)* | 8.1 (− 5.5; 21.6) |
Role functioning | 79.6 (21.7) | 80.2 (28.8) | − 0.6 (− 20.5; 19.3) |
Emotional functioning | 98.2 (5.6) | 83.8 (15.2)* | 14.4 (4.1; 24.6) |
Social functioning | 90.7 (16.9) | 90.5 (19.8)* | 0.2 (− 13.6; 14.1) |
Fatigue | 29.6 (24.8) | 27.1 (24.4) | 2.5 (− 14.8; 19.9) |
Nausea and vomiting | 11.1 (22.0) | 3.4 (9.9) | 7.7 (− 0.7; 16.2) |
Pain | 13.0 (20.0) | 16.2 (20.1) | − 3.2 (− 17.5; 11.1) |
Constipation | 7.4 (22.2) | 6.9 (14.9)* | 0.5 (− 10.8; 11.8) |
Diarrhea | 22.2 (37.3) | 19.1 (29.2)* | − 3.1 (− 18.3; 24.6) |